Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery

Cataract surgical outcomes in diabetic patients has been subject to changes with the advances in the surgical techniques. Recent studies suggest that cataract surgery does not cause the progression of diabetic retinopathy and intravitreal bevacizumab and/or triamcinolone injections combined with cat...

Full description

Saved in:
Bibliographic Details
Published in:International ophthalmology 2013-10, Vol.33 (5), p.605-610
Main Authors: Cetin, Ebru Nevin, Yıldırım, Cem
Format: Article
Language:English
Subjects:
Angiogenesis Inhibitors - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Antibodies, Monoclonal, Humanized - therapeutic use
Bevacizumab
Cataract - complications
Cataract - therapy
Chemotherapy, Adjuvant
Diabetic Retinopathy - complications
Diabetic Retinopathy - drug therapy
Disease Progression
Humans
Intravitreal Injections
Macular Edema - complications
Macular Edema - drug therapy
Medicine
Medicine & Public Health
Ophthalmology
Phacoemulsification
Ranibizumab
Review
Triamcinolone - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cataract surgical outcomes in diabetic patients has been subject to changes with the advances in the surgical techniques. Recent studies suggest that cataract surgery does not cause the progression of diabetic retinopathy and intravitreal bevacizumab and/or triamcinolone injections combined with cataract surgery may contribute in short term improvement of macular edema in diabetic patients. This article reviews the progression of diabetic retinopathy after cataract surgery with phacoemulsification and the use of adjuvant intravitreal treatments combined with phacoemusification in diabetic patients undergoing cataract surgery.
ISSN:0165-5701
1573-2630
DOI:10.1007/s10792-012-9695-1